Literature DB >> 8304478

Hepatocyte growth factor accelerates recovery from acute ischemic renal injury in rats.

S B Miller1, D R Martin, J Kissane, M R Hammerman.   

Abstract

Effects of hepatocyte growth factor (HGF) administration were examined in a model of acute ischemic renal injury induced by bilateral renal artery occlusion in rats. Compared with rats administered vehicle, rats administered 20 micrograms HGF subcutaneously 30 min postischemia had significantly lower serum creatinine and blood urea nitrogen levels over the course of 7 days postocclusion, enhanced insulin clearances measured on day 2 postocclusion, reduced mortality, and much less injury evident by examination of kidney histologies 7 days postinjury. The tubular regeneration that occurred postischemic injury was reflected by increased incorporation of 5-bromo-2'-deoxyuridine (BrdU) in cortical tubular epithelium compared with incorporation in kidneys from noninjured rats. HGF enhanced BrdU incorporation compared with vehicle, indicating enhanced mitogenesis. The weight loss that occurs postischemic injury was not ameliorated by the dose of HGF we employed. We conclude that administration of HGF postischemic injury to rats stimulates the recovery of normal kidney function and the regeneration of proximal tubular epithelium.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8304478     DOI: 10.1152/ajprenal.1994.266.1.F129

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  31 in total

1.  Use of mouse hematopoietic stem and progenitor cells to treat acute kidney injury.

Authors:  Ling Li; Rachel Black; Zhendong Ma; Qiwen Yang; Andrew Wang; Fangming Lin
Journal:  Am J Physiol Renal Physiol       Date:  2011-09-21

2.  Oral supplement of six selective amino acids arrest progression renal failure in uremic patients.

Authors:  Hippocrates Yatzidis
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

3.  Deleting the TGF-β receptor attenuates acute proximal tubule injury.

Authors:  Leslie Gewin; Sangeetha Vadivelu; Surekha Neelisetty; Manakan B Srichai; Paisit Paueksakon; Ambra Pozzi; Raymond C Harris; Roy Zent
Journal:  J Am Soc Nephrol       Date:  2012-11-15       Impact factor: 10.121

4.  Hepatocyte growth factor preferentially activates the anti-inflammatory arm of NF-κB signaling to induce A20 and protect renal proximal tubular epithelial cells from inflammation.

Authors:  Cleide G da Silva; Elizabeth R Maccariello; Szuhuei Wu Wilson; Prabhakar Putheti; Soizic Daniel; Scott M Damrauer; Clayton R Peterson; Jeffrey J Siracuse; Elzbieta Kaczmarek; Christiane Ferran
Journal:  J Cell Physiol       Date:  2012-04       Impact factor: 6.384

5.  Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease.

Authors:  S Mizuno; T Kurosawa; K Matsumoto; Y Mizuno-Horikawa; M Okamoto; T Nakamura
Journal:  J Clin Invest       Date:  1998-05-01       Impact factor: 14.808

6.  Hemodynamic effects of epidermal growth factor in conscious rats and monkeys.

Authors:  J A Keiser; M J Ryan
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

7.  MUC20 suppresses the hepatocyte growth factor-induced Grb2-Ras pathway by binding to a multifunctional docking site of met.

Authors:  Toshio Higuchi; Takuya Orita; Ken Katsuya; Yoshiki Yamasaki; Kiyotaka Akiyama; Huiping Li; Tadashi Yamamoto; Yutaka Saito; Motonao Nakamura
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

8.  Adult stem cell-like tubular cells reside in the corticomedullary junction of the kidney.

Authors:  Kyungeun Kim; Kyoung Mee Lee; Duck Jong Han; Eunsil Yu; Yong Mee Cho
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

9.  Application of regenerative medicine for kidney diseases.

Authors:  Takashi Yokoo; Akira Fukui; Eiji Kobayashi
Journal:  Organogenesis       Date:  2007-01       Impact factor: 2.500

10.  Renal expression of alpha-smooth muscle actin and c-Met in children with Henoch-Schönlein purpura nephritis.

Authors:  Yukihiko Kawasaki; Tomoko Imaizumi; Hiromi Matsuura; Shinichirou Ohara; Kei Takano; Kazuhide Suyama; Koichi Hashimoto; Ruriko Nozawa; Hitoshi Suzuki; Mitsuaki Hosoya
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.